Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Skin Metastases|Stage IV Breast Cancer
Interventions: DRUG: imiquimod|DRUG: Abraxane|OTHER: laboratory biomarker analysis|GENETIC: RNA analysis|OTHER: immunoenzyme technique
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)